Nanotechnology in Pharmaceutical R&D: Drug Delivery System

Jul 25, 2017

Pharmaceutical industry now utilize Nanotechnology as a platform for new technology development. It is the science that deals with the processes that occur at molecular level and of nanolength scale size. It opened new opportunities for improvement in different aspects of pharmaceutical manufacturing, e.g. drug designing.

The scope of pharmaceutical nanotechnology is very wide, from smart material for tissue engineering to intelligent tools for delivery of drugs. Novel drug delivery comprises a number of features of nanotechnology, and its importance is in the concept and ability to manipulate molecules and supramolecules for producing devices with programmed function. Examples of the current nano drug delivery systems are: liposomes, polymeric micelles, nanoparticles, and dendrimers.

Liposomes are small artificial vesicles of spherical shape that can be created from cholesterol and natural non-toxic phospholipids. They are the most developed nanotechnology product for the novel and targeted drug delivery due to their size and amphiphilic (hydrophobic-hydrophilic) character. They have been successfully used in cancer therapy, pulmonary delivery, ophthalmic drug delivery, leishmaniasis, and as carrier for antigens.

Polymeric micelles are nanoscopic supramolecular core-shell structure that is composed of amphiphilic block copolymers. They are used for the systemic delivery of water-insoluble drugs. Polymeric micelles have proved an excellent novel drug delivery system due to high and versatile loading capacity, stability in physiological conditions, slower rate of dissolution, high accumulation of drug at target site, and possibility of functionalization of end group for conjugation of targeting ligands.

Nanoparticles can be classified into two groups: (1) Polymeric nanoparticles; and (2) Metallic nanoparticles. Polymeric nanoparticles are colloidal carriers having inherent properties like biocompatibility, nonimmunogenicity, nontoxicity, and biodegrability. They are usually used for intracellular and site specific delivery. For metallic nanoparticles, they are good delivery carriers for drug and biosensor. Silver and gold nanoparticles are of great importance for biomedical use among all metallic nanoparticles.

Dendrimers are hyperbranched, tree-like structures and have compartmentalized chemical polymer. They bear promising properties for delivery of bioactives ranging from drugs, vaccines, metal, and genes to desired sites. Most important applications of dendrimers are gene therapy, immunoassay, and MRI contrast agent.

The use of these carriers allows for a much higher active moiety/carrier material ratio compared to "direct" molecular conjugates, and is also capable of carrying multiple drug species. They also provide a higher degree of protection from enzymatic degradation and other destructive factors upon administration because the carrier wall completely isolates drug molecules from the environment.

The method of preparation for nanopharmaceuticals will always vary depending on the physical character of the polymer and the active ingredient used. For example, for nanopharmaceuticals used in ophthalmology, the ultimate goal is to keep the product sterile or free from contaminating microorganisms. To make it possible, it is advised to use an isolation system in preparing this type of drug. It is required to maintain a positive pressure so as to maintain the sterility of the product. However, for nanopharmaceuticals containing cytotoxic drugs, the requirement is unique for its preparation since hazardous substances are involved. The product should still be sterile and free from contamination, without compromising the safety of the operator and the environment.

These novel drug delivery systems offer tremendous opportunity for development of site-specific delivery systems for drugs and genes. They are especially critical in an era of rising healthcare cost and development of multidrug resistance in cancer and infectious diseases. Esco Pharma supports this by promoting research and providing continuous innovation from discovery up to the delivery of drugs. Thereby, improving the healthcare industry.

References:

  1. Mansoor M. Amiji, Nanotechnology for Drug Delivery: An Overview. Northeastern University, Boston, 2006.

  2. N.K. Jain, Pharmaceutical Technology: Pharmaceutical Nanotechnology, 2007.

  3. Saurabh Bhatia, Nanotechnology and Its Drug Delivery Applications, 2016.

Other News


Raising Your Standards with Esco Downflow Booth
Airflow Containment on Its Best

Date: Nov 29, 2017


Bio-decontamination Within
The Efficiency of Esco BioVap™ Inside the Isolators

Date: Nov 28, 2017


Esco Pharma GB exhibited at CPhI and P-Mec in Germany

Date: Nov 08, 2017


Survivor 101: Safe Change Filtration

Date: Nov 07, 2017


The Horror Behind the Gross Art of Sneeze and Cough

Date: Oct 27, 2017


Esco Life Sciences and Healthcare is Strengthening its Core in Biocontainment

Date: Oct 18, 2017


Esco Pharma is at Two Places at Once

Date: Oct 05, 2017


A Perfect Mate

Date: Sep 27, 2017


Nanotechnology: Containment Strategies and Engineering Controls

Date: Sep 26, 2017


It’s more than just being Fragile : How to Handle Potent Formulation?

Date: Sep 25, 2017


Innovative Solutions for the Next Generation: Esco Pharma at ISPE 2017

Date: Aug 30, 2017


How SAFE is your FOOD?

Date: Aug 30, 2017


Inhaled Insulin: Boon or Bane?

Date: Aug 11, 2017


Esco Pharma at High Potent Medicines Conference 2017

Date: Jun 21, 2017


Quality Assurance System

Date: Jun 16, 2017


Defects

Date: Jun 16, 2017


Esco Pharma GB is moving!

Date: May 30, 2017


Esco Pharma at INTERPHEX 2017

Date: Apr 04, 2017


Esco Isoclean® Isolators Aid in a Pharmacy Compounding Facility in Singapore

Date: Mar 17, 2017


Esco Pharma Advancing Aseptic Pharmaceutical Processing with SP Scientific PennTech and ESS Technologies

Date: Jan 26, 2017


Esco joins the biggest pharma event in South Asia!

Date: Nov 28, 2016


Feeling Alienated by Safety?

Date: Dec 01, 2016


Blow-Fill-Seal Technology and Isolators

Date: Nov 22, 2016


How Clean is Clean Enough?

Date: Nov 08, 2016


Why isolators are still preferred when handling HPAPIs?

Date: Oct 27, 2016


Be SAFE in Handling High Potency APIs

Date: Oct 26, 2016


Cytotoxic Drugs: Safe Handling in the Workplace!

Date: Oct 17, 2016


Esco isolator finally arrives in the land of the rising sun

Date: Sep 26, 2016


Esco Healthcare exhibits at the 16th ISPE – Singapore Affiliate

Date: Sep 16, 2016


Unidirectional or Turbulent Airflow: Which is best for Sterile Pharmacy Compounding?

Date: Sep 01, 2016


Discover the most diverse compounding pharmacy isolators

Date: Aug 18, 2016


The need for engineering controls in preventing compounding pharmacy mishaps

Date: Jul 19, 2016


Esco at the ASHP in Baltimore!

Date: Jun 23, 2016


Esco at the 2016 PPhA National Convention in Cebu City

Date: Jun 01, 2016


Esco Pharma ships out General Processing Platform Isolator (GPPI) to a client in Canada

Date: Jan 04, 2016


Esco Launches VacciXcell and TapestleRx

Date: Dec 03, 2015


VacciXcell commences the 1st day of exhibition at the Europe Vaccine Congress 2015 in Madrid

Date: Nov 10, 2015


Esco Pharma exhibited concurrently in Pharma Expo Las Vegas and IPEX Packaging Expo in Jakarta

Date: Oct 07, 2015


Esco Pharma partners with UP College of Pharmacy

Date: Jul 09, 2015


Thank you for visiting Esco at ACHEMA 2015!

Date: Jun 26, 2015


Esco at ISPE Exhibition

Date: Jun 09, 2015


Esco Pharma is Proud to Launch its New Range of Containment Isolators

Date: Apr 28, 2015


Esco GB Ltd hosted the 2014 Training at its new premises in Barnsley

Date: Dec 15, 2014


Esco Pharma at ISPE Event in Singapore.

Date: Aug 13, 2014


Esco at INTERPHEX 2014!

Date: Jul 17, 2014